ArticleFrontiers in immunology2025

A case report of advanced pancreatic neuroendocrine carcinoma with Ki67 80%, CPS 0, and pMMR achieving durable complete response for over 7 years after combination immunotherapy.

Weiqiang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.